However, variation in individual risk profiles, driven by poor adherence and inconsistent behavioral change, as well as other factors, underscores the need for nuance in program design and application
Challenges Along the Way Like any treatment, there were some initial side effects, including mild nausea
While switching from semaglutide (a GLP-1 agonist) to tirzepatide (a GIP/GLP-1 co-agonist) worsened symptoms, including nausea and epigastric pain, ultimately leading to acute duodenal ulcer perforation, exact contributing factors are unclear
A doctor will usually perform a physical exam in addition to diagnostic tests
Semaglutide for weight loss has become one of the most talked-about medical breakthroughs of the decade and for good reason